INTERLEUKIN (IL)-1 INHIBITION WITH ANAKINRA AND CANAKINUMAB IN BEHCET'S DISEASE RELATED UVEITIS: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY
FRI0586 Interleukin (IL)-1 inhibition with anakinra and canakinumab in behÇet's disease related uveitis: a multicenter retrospective observational study / Fabiani, C; Vitale, A; Emmi, G; Lopalco, G; Vannozzi, L; Guerriero, S; Gentileschi, S; Bacherini, D; Franceschini, R; Frediani, B; Galeazzi, M; Iannone, F; Tosi, GM; Cantarini, L. - ELETTRONICO. - 76:(2017), pp. 711.1-711. (Intervento presentato al convegno Annual European Congress of Rheumatology) [10.1136/annrheumdis-2017-eular.1119].
FRI0586 Interleukin (IL)-1 inhibition with anakinra and canakinumab in behÇet's disease related uveitis: a multicenter retrospective observational study
Fabiani, C;Emmi, G;Vannozzi, L;Bacherini, D;Galeazzi, M;
2017
Abstract
INTERLEUKIN (IL)-1 INHIBITION WITH ANAKINRA AND CANAKINUMAB IN BEHCET'S DISEASE RELATED UVEITIS: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDYFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.